Opportunities for enhancing the FDA guidance on pharmacovigilance
JAMA
.
2008 Aug 27;300(8):952-4.
doi: 10.1001/jama.300.8.952.
Authors
Bruce M Psaty
1
,
Jan P Vandenbroucke
Affiliation
1
Cardiovascular Health Research Unit, Department of Medicine, University of Washington and Center for Health Studies, Group Health, Seattle, WA 98101, USA. psaty@u.washington.edu
PMID:
18728269
DOI:
10.1001/jama.300.8.952
No abstract available
Publication types
Research Support, N.I.H., Extramural
MeSH terms
Clinical Trials as Topic*
Consumer Product Safety*
Observation
Randomized Controlled Trials as Topic
United States
United States Food and Drug Administration*
Grant support
HL080295/HL/NHLBI NIH HHS/United States
HL085251/HL/NHLBI NIH HHS/United States
HL087652/HL/NHLBI NIH HHS/United States
HL74745/HL/NHLBI NIH HHS/United States